Hyperlipemia therapeutic agent
US7776881B2 · kind B2 · utility
103Cited by
6References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 5, 2005 |
| Grant date | Aug 17, 2010 |
| Priority date | — |
| Expiry date | Sep 9, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A hypertriglyceridemia therapeutic agent made up of a synergistically effective blood-triglyceride decreasing amount of a combination of a pitavastatin and eicosapentaenoic acid (EPA), or an ester thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.